Login / Signup

Phase II Study of Avelumab in Patients with Advanced Hepatocellular Carcinoma Previously Treated with Sorafenib.

Youngeun LeeEun Ju ChoSu Jong YuYoon Jun KimJung-Hwan YoonTae-Yong KimSae-Won HanDo-Youn OhSeock-Ah ImTae-You KimHaeryoung KimKyung-Hun Lee
Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2020)
Avelumab showed moderate efficacy and was well tolerated in advanced hepatocellular carcinoma previously treated with sorafenib.
Keyphrases
  • phase ii study
  • open label
  • locally advanced
  • high intensity
  • newly diagnosed
  • clinical trial
  • radiation therapy
  • rectal cancer
  • placebo controlled